SR9009 improves heart function after pressure overload independent of cardiac REV-ERB.

Saved in:
Bibliographic Details
Title: SR9009 improves heart function after pressure overload independent of cardiac REV-ERB.
Authors: Li H; Department of Molecular and Human Genetics, Baylor College of Medicine, Houston, TX, United States., Song S; Division of Diabetes, Department of Medicine, Endocrinology and Metabolism, Baylor College of Medicine, Houston, TX, United States., Tien CL; Department of Molecular and Human Genetics, Baylor College of Medicine, Houston, TX, United States., Qi L; Department of Molecular and Human Genetics, Baylor College of Medicine, Houston, TX, United States., Graves A; Department of Molecular and Human Genetics, Baylor College of Medicine, Houston, TX, United States., Nasiotis E; Department of Molecular and Human Genetics, Baylor College of Medicine, Houston, TX, United States., Burris TP; Genetics Institute, University of Florida, Gainesville, FL, United States., Zhao Y; Department of Molecular and Human Genetics, Baylor College of Medicine, Houston, TX, United States., Sun Z; Division of Diabetes, Department of Medicine, Endocrinology and Metabolism, Baylor College of Medicine, Houston, TX, United States.; Department of Molecular and Cellular Biology, Baylor College of Medicine, Houston, TX, United States., Zhang L; Department of Molecular and Human Genetics, Baylor College of Medicine, Houston, TX, United States.
Source: Frontiers in cardiovascular medicine [Front Cardiovasc Med] 2022 Jul 14; Vol. 9, pp. 952114. Date of Electronic Publication: 2022 Jul 14 (Print Publication: 2022).
Publication Type: Journal Article
Journal Info: Publisher: Frontiers Media S.A Country of Publication: Switzerland NLM ID: 101653388 Publication Model: eCollection Cited Medium: Print ISSN: 2297-055X (Print) Linking ISSN: 2297055X NLM ISO Abbreviation: Front Cardiovasc Med Subsets: PubMed not MEDLINE
Database: MEDLINE Ultimate
Description
ISSN:2297-055X
DOI:10.3389/fcvm.2022.952114